文献速递消化道肿瘤放疗

FAPI-PET/CT引导食管癌放疗的回顾性分析

FAPI-PET/CT guided radiotherapy for patients with esophageal cancer.
PubMed 文献 · Radiat Oncol · 2025-02-28

回顾性分析10例新诊断食管癌患者,均行[68Ga]OncoFAP-PET/CT定位以辅助放疗计划制定,其中6例接受新辅助放化疗、4例接受根治性放化疗,5例在初始治疗后行FAPI-PET/CT再分期。结果显示[68Ga]OncoFAP-PET/CT与内镜分期高度相关,3例发现了CT和超声内镜分期未显示的新病灶,对靶区勾画(尤其心后/心旁区和胃食管交界处)有良好显示。作者认为[68Ga]OncoFAP-PET/CT可能有助于改善食管癌放疗计划制定。

要点

  • 10例食管癌患者行[68Ga]OncoFAP-PET/CT定位,其中6例新辅助、4例根治性放化疗。
  • FAPI-PET/CT与内镜分期高度相关,3例发现CT和超声内镜未显示的新病灶。
  • FAPI-PET/CT对心后/心旁区和胃食管交界处靶区勾画显示良好。

核心结论

  • [68Ga]OncoFAP-PET/CT可能有助于改善食管癌患者的放疗计划制定。

研究设计与样本

  • 回顾性分析10例新诊断并接受放化疗的食管癌患者,均行[68Ga]OncoFAP-PET/CT定位以辅助放疗计划制定。
  • 6例接受新辅助放化疗作为三联治疗的一部分,4例接受根治性放化疗;5例在初始治疗后行FAPI-PET/CT再分期。

主要发现

  • [68Ga]OncoFAP-PET/CT初始成像与内镜分期高度相关。
  • 3例发现了CT和超声内镜分期未显示的新病灶部位。
  • [68Ga]OncoFAP-PET/CT靶区勾画对临床靶区显示良好,尤其在心后/心旁区和胃食管交界处。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer associated fibroblasts have become a target of interest in different malignancies for positron emission tomography (PET) imaging, using positron emitter labelled fibroblast activation protein inhibitors (FAPI). New data underline the advanced imaging properties of FAPI-PET/CT for the staging of esophageal cancer compared to standard imaging. Potential benefits of FAPI-PET/CT in radiation therapy planning are the subject of this investigation. METHODS: Ten patients with newly diagnosed esophageal cancer treated with radiochemotherapy (RCT) were retrospectively analyzed. All patients underwent [68Ga]OncoFAP-PET/CT in treatment position to facilitate radiation treatment planning. Six patients received neoadjuvant RCT as part of a trimodal therapy and four patients underwent definitive RCT. In five cases, restaging after initial treatment was performed with FAPI-PET/CT. RESULTS: [68Ga]OncoFAP-PET/CT based imaging showed a high correlation with the endoscopic staging for initial imaging. In three cases, new sites of disease were unmasked, not visible in CT- and endosonographic staging. [68Ga]OncoFAP-PET/CT based RT delineation offered good definition of clinical target volumes, especially in retro-/paracardial areas and the gastroesophageal junction. CONCLUSION: [68Ga]OncoFAP-PET/CT may aid and improve radiation treatment planning for patients with esophageal cancer.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kröger K, Pepper NB, Ventura D, et al. FAPI-PET/CT guided radiotherapy for patients with esophageal cancer. Radiat Oncol. 2025. PMID: 40022163. doi:10.1186/s13014-025-02606-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。